Digital retail pharmacy Dingdang Health Technology Group Ltd. (09886.HK) announced on Friday it expects to report its net loss last year narrowed by more than 80% from about 380 million yuan ($55 million) in 2024, implying a roughly 76 million yuan loss for 2025.
On a non-IFRS basis, the company expects to record an adjusted net profit of 5 million yuan or more for last year, compared with an adjusted net loss of about 57.2 million yuan the previous year.
The company attributed the sharp improvement mainly to a significant reduction in goodwill and other intangible asset impairment losses booked in 2024. It also said it continued to improve its strategy by focusing on core tier-one markets such as Beijing, Shanghai and Shenzhen, expanding its smart pharmacy network to boost operating efficiency and support steady business growth.
Dingdang said it also strengthened its supply chain capabilities and improved its product mix to include a bigger share of higher-margin categories.
Dingdang Health’s stock opened flat on Friday and closed at HK$0.89 by the midday break, down 2.2%. The stock is up about 51% over the last 52 weeks.
By Lee Shih Ta
To subscribe to Bamboo Works weekly free newsletter, click here
